Synthetic TLR9-ligands (CpG-sequence containing oligonucleotides) stimulated TLR9 expressed on cancer cells as well as various normal cells, including mesenchymal stem cells and stimulated their invasion in vitro. The gene discussed is TLR9; the disease is cancer.